Finance
The investment chief at $7 billion healthcare specialist Perceptive Advisors breaks down why the COVID-19 vaccine race will have many winners — and explains how his firm is taking advantage of the massive Chinese market
Longtime healthcare, pharmaceutical, and biotech investor Perceptive Advisors sees a future where a vaccine for the coronavirus is being mass-produced and distributed...